Bank of New York Mellon Corp - BELLEROPHON THERAPEUTICS INC ownership

BELLEROPHON THERAPEUTICS INC's ticker is BLPH and the CUSIP is 078771102. A total of 26 filers reported holding BELLEROPHON THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of BELLEROPHON THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$60,000
-26.8%
170,6720.0%0.00%
Q3 2019$82,000
-19.6%
170,6720.0%0.00%
Q2 2019$102,000
-10.5%
170,672
-2.4%
0.00%
Q1 2019$114,000
-18.6%
174,874
-0.0%
0.00%
Q4 2018$140,000
-25.9%
174,9020.0%0.00%
Q3 2018$189,000
-55.3%
174,9020.0%0.00%
Q2 2018$423,000
+15.3%
174,902
-0.7%
0.00%
Q1 2018$367,000
-19.9%
176,117
-0.7%
0.00%
Q4 2017$458,000177,4290.00%
Other shareholders
BELLEROPHON THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Puissance Capital Management LP 8,298,755$17,261,00014.88%
NEW MOUNTAIN VANTAGE ADVISERS, L.L.C. 15,138,486$31,488,0002.58%
VHCP Management II, LLC 4,149,378$8,631,0002.08%
Boxer Capital, LLC 1,857,143$3,863,0000.41%
Telemetry Investments, L.L.C. 199,000$414,0000.16%
EAM Investors, LLC 232,290$483,0000.08%
DRW Securities, LLC 70,000$146,0000.01%
Renaissance Technologies 1,032,900$2,148,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 23,000$48,0000.00%
STATE STREET CORP 13,800$29,0000.00%
View complete list of BELLEROPHON THERAPEUTICS INC shareholders